Director
GlaxoSmithKline
Disclosure: GlaxoSmithKline (Employee)
James (Jim) Brown, is Director and Senior Fellow in Computational Biology, Human Genetics for GlaxoSmithKline Pharmaceutical R&D, Collegeville, Pennsylvania. He has applied bioinformatics to drug discovery in the microbiome, infectious diseases, oncology and metabolic, neurological and respiratory diseases. He developed an innovative host-pathogen target strategy using human genetics and functional genomics. Most recently, he is leading the genomics/genetics component of GSK’s COVID-19 response by finding novel human targets for infectious disease with the companies Vir and 23andMe. Jim graduated with a B.Sc. Marine Biology from McGill University and earned M.Sc. and Ph.D. degrees from Simon Fraser University. He was a recipient of a Medical Research Council of Canada Post-doctoral Fellowship with Dr. W. Ford Doolittle, Dalhousie University. With 24 years of pharmaceutical R&D experience he has over 110 publications and serves on multiple academic and industrial panels.
